[CLDX] YoY Quarter Result on 30-Sep-2010 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
04-Nov-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- 4.60%
YoY- -26.67%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Revenue 980 3,113 2,363 2,408 4,030 2,358 1,192 -3.20%
PBT -23,140 -15,027 -11,334 -8,755 -7,174 -7,656 -5,373 27.52%
Tax -142 -105 -288 -248 36 -922 -120 2.84%
NP -23,140 -15,027 -11,772 -9,087 -7,174 -7,656 -5,253 28.00%
Tax Rate - - - - - - - -
Total Cost 24,120 18,140 14,135 11,495 11,204 10,014 6,445 24.57%
Ratio Analysis
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
NP Margin -2,361.22 -482.72 -498.18 -377.37 -178.01 -324.67 -440.90 32.23%
Per Share
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
EPS -4.28 -3.79 -4.00 -4.27 -6.78 -7.31 -113.80 -42.08%
EPS Diluted -4.28 -3.79 -4.00 -4.27 -6.78 -7.31 -113.80 -42.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.